We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Agilent Technologies Introduces Verified Dissolution Components for Pharmaceutical Market

News   May 15, 2013

 
Agilent Technologies Introduces Verified Dissolution Components for Pharmaceutical Market
 
 
Advertisement
 

RELATED ARTICLES

Wuhan COVID-19 Vaccine Trials Show Early Positive Results, Moving Forward to Phase 3 Testing

News

The adenovirus type-5-vectored COVID-19 vaccine was shown to be safe and induced significant immune responses in the majority of recipients after a single immunization.

READ MORE

Survey Highlights the Effects of COVID-19 Pandemic on Life Scientists

News

Jan Korbel and Oliver Stegle, both group leaders at EMBL Heidelberg, have performed a survey of fellow life scientists in Germany, Spain, the UK, Italy, France, Canada, Turkey, and the USA to learn how the current crisis, with partial or complete institutional shutdowns, is affecting their work.

READ MORE

Expanding the Use of Metal Catalysts in Drug Discovery

News

The use of metals in drug molecules could offer major benefits, for example enabling lower therapeutic dosages to be used and could result in fewer side effects.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE